Abstract:The global increase in cancer incidence presents significant economic and societal challenges. While chimeric antigen receptor-modified T cell (CAR-T) therapy has demonstrated remarkable success in hematologic malignancies and has earned FDA approval, its translation to solid tumors encounters faces significant obstacles, primarily centered around identifying reliable tumor-associated antigens and navigating the complexities of the tumor microenvironment. Recent developments in single-cell RNA sequencing (scRNA-seq) have greatly enhanced our understanding of tumors by offering high-resolution, unbiased analysis of cellular heterogeneity and molecular patterns. These technologies have revolutionized our comprehension of tumor immunology and have led to notable progress in cancer immunotherapy. This mini-review explores the progress of chimeric antigen receptor (CAR) cell therapy in solid tumor treatment and the application of scRNA-seq at various stages following the administration of CAR cell products into the body. The advantages of scRNA-seq are poised to further advance the investigation of the biological characteristics of CAR cells in vivo, tumor immune evasion, the impact of different cellular components on clinical efficacy, the development of clinically relevant biomarkers, and the creation of new targeted drugs and combination therapy approaches. The integration of scRNA-seq with CAR therapy represents a promising avenue for future innovations in cancer immunotherapy. This synergy holds the potential to enhance the precision and efficacy of CAR cell therapies while expanding their applications to a broader range of malignancies.

Pan-cancer Tumor-Infiltrating T Cells: A Great Hallmark in Cancer Immunology Research

T-cell infiltration and its regulatory mechanisms in cancers: insights at single-cell resolution

Recharacterizing Tumor-Infiltrating Lymphocytes by Single-Cell RNA Sequencing

Single-cell RNA sequencing in cancer research: discovering novel biomarkers and therapeutic targets for immune checkpoint blockade

Significance of intratumoral infiltration of B cells in cancer immunotherapy: From a single cell perspective

Deciphering cell-cell interactions and communication in the tumor microenvironment and unraveling intratumoral genetic heterogeneity via single-cell genomic sequencing

Single-cell RNA Sequencing in Cancer: Applications, Advances, and Emerging Challenges

Progress and Clinical Application of Single-Cell Transcriptional Sequencing Technology in Cancer Research

Understanding tumor-infiltrating lymphocytes by single cell RNA sequencing

Single-cell analysis technologies for cancer research: from tumor-specific single cell discovery to cancer therapy

The Application of Single-Cell Sequencing in Pancreatic Neoplasm: Analysis, Diagnosis and Treatment

Integrative insights and clinical applications of single-cell sequencing in cancer immunotherapy

Revolutionizing cancer immunotherapy in solid tumor: CAR engineering and single-cell sequencing insights

Insights Gained from Single-Cell Analysis of Immune Cells in the Tumor Microenvironment

Progress of single-cell RNA sequencing combined with spatial transcriptomics in tumour microenvironment and treatment of pancreatic cancer

Promising immunotherapeutic targets in lung cancer based on single-cell RNA sequencing

Cancer Biology Deciphered by Single-Cell Transcriptomic Sequencing

Advances in single-cell RNA sequencing and its applications in cancer research

Single-Cell RNA-Sequencing: Opening New Horizons for Breast Cancer Research

Prudent Application of Single-Cell RNA Sequencing in Understanding Cellular Features and Functional Phenotypes in Cancer Studies

[Advancements in Single-cell RNA Sequencing Technology in the Study of the Tumor Microenvironment in Lung Cancer]